A new experimental treatment for multiple sclerosis MS completely reverses the devastating autoimmune disorder in mice, and might work exactly the same way in humans, say researchers at the Jewish General Hospital Lady Davis Institute for Medical Research and McGill University in Montreal.

MS is an autoimmune disease in which the body’s own immune response attacks the central nervous system, almost as if the body had become allergic to itself, leading to progressive physical and cognitive disability.

The new treatment, appropriately named GIFT15, puts MS into remission by suppressing the immune response. This means it might also be effective against other autoimmune disorders like Crohn’s disease, lupus and arthritis, the researchers said, and could theoretically also control immune responses in organ transplant patients. Moreover, unlike earlier immune-supppressing therapies which rely on chemical pharamaceuticals, this approach is a personalized form of cellular therapy which utilizes the body’s own cells to suppress immunity in a much more targeted way.

read the rest via Multiple Sclerosis Successfully Reversed In Mice: New Immune-suppressing Treatment Forces The Disease Into Remission.

  •  

     

     

     

  •  

     

     

  • Important Notice

    This site posts excerpts and summaries of articles of interest to people with multiple sclerosis and their families, along with links to the full articles in the journals in which they were published.

    I have multiple sclerosis (primary progressive), but I am neither a doctor nor a research scientist. I have no connection to the people mentioned in these articles, and have no more information about the subject of any given article than is contained in the article itself. Please do not ask me for medical advice or how to contact people mentioned in these articles. If contact information is not contained in the article itself, your best bet is to Google the name of the person, company or clinic you are seeking.